Cargando…

Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma

Tertiary lymphoid structures (TLS) are ectopic lymphoid structures in cancers that are largely associated with favourable prognosis. However, the prognostic value of TLSs in oral squamous cell carcinoma (OSCC) is largely unknown, and the association between tumour infiltrating lymphocytes (TILs) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qunxing, Liu, Xiangqi, Wang, Dikan, Wang, Yanqiong, Lu, Huanzi, Wen, Shuqiong, Fang, Juan, Cheng, Bin, Wang, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493903/
https://www.ncbi.nlm.nih.gov/pubmed/32934197
http://dx.doi.org/10.1038/s41368-020-00092-3
_version_ 1783582651258503168
author Li, Qunxing
Liu, Xiangqi
Wang, Dikan
Wang, Yanqiong
Lu, Huanzi
Wen, Shuqiong
Fang, Juan
Cheng, Bin
Wang, Zhi
author_facet Li, Qunxing
Liu, Xiangqi
Wang, Dikan
Wang, Yanqiong
Lu, Huanzi
Wen, Shuqiong
Fang, Juan
Cheng, Bin
Wang, Zhi
author_sort Li, Qunxing
collection PubMed
description Tertiary lymphoid structures (TLS) are ectopic lymphoid structures in cancers that are largely associated with favourable prognosis. However, the prognostic value of TLSs in oral squamous cell carcinoma (OSCC) is largely unknown, and the association between tumour infiltrating lymphocytes (TILs) and TLSs has been rarely explored in OSCC. In this study, associated markers of TLS, including peripheral node address (PNAd) in high endothelial venules, CD20 in B cells and CD3 in T cells, were examined in 168 OSCC patients, and survival analysis was performed between TLS-positive and TLS-negative cohorts. We detected the presence of TILs by staining CD8+ cytotoxic T cells and CD57+ NK cells as well. TLSs appeared as highly organized structures in 45 (26.8%) cases. TLS-positive patients had a better 5-year overall survival (OS) rate (88.9% vs. 56.1%, P < 0.001) and relapse-free survival (RFS) rate (88.9% vs. 63.4%, P = 0.002). Moreover, the presence of TLS was an independent prognostic factor for both the 5-year OS rate (hazard ratio [HR] = 3.784; 95% confidence interval [CI], 1.498–9.562) and RFS rate (HR = 3.296; 95% CI, 1.279–8.490) in multivariate analysis. Furthermore, a higher density of CD8+ T cells and CD57+ NK cells was found in TLS-positive sections than in TLS-negative counterparts (P < 0.001), and their combination provided a higher predictive accuracy (AUC = 0.730; 95% CI, 0.654–0.805). In conclusion, our results suggest that TLS is an independent positive prognostic factor for OSCC patients. These findings provide a theoretical basis for the future diagnostic and therapeutic value of TLSs in OSCC treatment.
format Online
Article
Text
id pubmed-7493903
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74939032020-10-01 Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma Li, Qunxing Liu, Xiangqi Wang, Dikan Wang, Yanqiong Lu, Huanzi Wen, Shuqiong Fang, Juan Cheng, Bin Wang, Zhi Int J Oral Sci Article Tertiary lymphoid structures (TLS) are ectopic lymphoid structures in cancers that are largely associated with favourable prognosis. However, the prognostic value of TLSs in oral squamous cell carcinoma (OSCC) is largely unknown, and the association between tumour infiltrating lymphocytes (TILs) and TLSs has been rarely explored in OSCC. In this study, associated markers of TLS, including peripheral node address (PNAd) in high endothelial venules, CD20 in B cells and CD3 in T cells, were examined in 168 OSCC patients, and survival analysis was performed between TLS-positive and TLS-negative cohorts. We detected the presence of TILs by staining CD8+ cytotoxic T cells and CD57+ NK cells as well. TLSs appeared as highly organized structures in 45 (26.8%) cases. TLS-positive patients had a better 5-year overall survival (OS) rate (88.9% vs. 56.1%, P < 0.001) and relapse-free survival (RFS) rate (88.9% vs. 63.4%, P = 0.002). Moreover, the presence of TLS was an independent prognostic factor for both the 5-year OS rate (hazard ratio [HR] = 3.784; 95% confidence interval [CI], 1.498–9.562) and RFS rate (HR = 3.296; 95% CI, 1.279–8.490) in multivariate analysis. Furthermore, a higher density of CD8+ T cells and CD57+ NK cells was found in TLS-positive sections than in TLS-negative counterparts (P < 0.001), and their combination provided a higher predictive accuracy (AUC = 0.730; 95% CI, 0.654–0.805). In conclusion, our results suggest that TLS is an independent positive prognostic factor for OSCC patients. These findings provide a theoretical basis for the future diagnostic and therapeutic value of TLSs in OSCC treatment. Nature Publishing Group UK 2020-09-15 /pmc/articles/PMC7493903/ /pubmed/32934197 http://dx.doi.org/10.1038/s41368-020-00092-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Li, Qunxing
Liu, Xiangqi
Wang, Dikan
Wang, Yanqiong
Lu, Huanzi
Wen, Shuqiong
Fang, Juan
Cheng, Bin
Wang, Zhi
Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
title Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
title_full Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
title_fullStr Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
title_full_unstemmed Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
title_short Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
title_sort prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493903/
https://www.ncbi.nlm.nih.gov/pubmed/32934197
http://dx.doi.org/10.1038/s41368-020-00092-3
work_keys_str_mv AT liqunxing prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma
AT liuxiangqi prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma
AT wangdikan prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma
AT wangyanqiong prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma
AT luhuanzi prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma
AT wenshuqiong prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma
AT fangjuan prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma
AT chengbin prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma
AT wangzhi prognosticvalueoftertiarylymphoidstructureandtumourinfiltratinglymphocytesinoralsquamouscellcarcinoma